Evaluation of Acute Coronary Syndrome in Patients with Chronic Renal Failure
[1]
Sokol Myftiu, Service of Cardiology, University Hospital Center “Mother Theresa”, Tirana, Albania.
[2]
Artan Shkoza, Biomedical and Experimental Department, Faculty of Medicine, University of Medicine, Tirana, Albania.
[3]
Vera Halili, Faculty of Medical Sciences, Albanian University, Tirana, Albania.
[4]
Gentian Vyshka, Biomedical and Experimental Department, Faculty of Medicine, University of Medicine, Tirana, Albania.
Chronic renal failure is a highly complicated occurrence, with severe metabolic and functional changes affecting almost the entirety of body organs. Coronary artery syndrome and angina events are encountered with an increased prevalence among patients suffering from renal failure, even more during end-stage renal injury. We have studied retrospectively a group of patients suffering from a coronary episode concomitant to the chronic renal failure which served as the background disorder. Patients suffering from chronic renal failure will present higher morbidity and mortality when a stenotic coronary artery will become symptomatic. Metabolic changes following renal dysfunction play an important role toward the acceleration of atherosclerotic changes commonly found in this group of patients. A holistic approach to all accompanying risk factors, through an individualized and timely pharmacological treatment will help producing better final outcomes for chronic renal failure patients that present with a coronary artery episode.
Acute Coronary Syndrome, Chronic Renal Failure, Coronary Artery Syndrome, Myocardial Infarction
[1]
Levin A. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47:S11–5.
[2]
Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 2005; 67:2089–100.
[3]
McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury N, Weaver WD, Sandberg KR, McCord J. Emergency evaluation of chest pain in patients with advanced kidney disease. Arch Intern Med. 2002 Nov 25; 162(21):2464-8.
[4]
McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury NE, Weaver WD, Sandberg KR, McCord J. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med. 2002 Dec; 9(12):1389-96.
[5]
Freynhofer MK, Tajsić M, Wojta J, Huber K. Biomarkers in acute coronary artery disease. Wien Med Wochenschr. 2012 Nov; 162(21-22):489-98.
[6]
McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003 Mar 5; 41(5):725-8.
[7]
McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011 Jan; 124(1):40-7.
[8]
Guérin AP, Pannier B, Marchais SJ, London GM. Arterial structure and function in end-stage renal disease. Curr Hypertens Rep. 2008 Apr; 10(2):107-11.
[9]
Cottone S, Lorito MC, Riccobene R, Nardi E, Mulè G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol. 2008 Mar-Apr; 21(2):175-9.
[10]
Eknoyan G. Adolphe Quetelet (1796-1874)--the average man and indices of obesity. Nephrol Dial Transplant. 2008 Jan; 23(1):47-51.
[11]
Thomas AE, McKay DA, Cutlip MB. A nomograph method for assessing body weight. Am J Clin Nutr. 1976 Mar; 29(3):302-4.
[12]
Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007 May; 2(3):550-62.
[13]
Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007 Jul 3; 116(1):85-97.
[14]
Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, Myrda K, Lekston A, Poloński L, Rozentryt P. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014 Nov; 29(11):801-12.
[15]
Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM; Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014 May 24; 383(9931):1831-43.
[16]
Strada E, Savazzi G. [From kidney disease to ischemic heart disease]. Recenti Prog Med. 2011 Apr; 102(4):166-71.
[17]
Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006 Mar 21; 47(6):1108-16.
[18]
Udeanu M, Guizzardi G, Di Pasquale G, Marchetti A, Romani F, Dalmastri V, Capelli I, Stalteri L, Cianciolo G, Rucci P, La Manna G. Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study. BMC Nephrol. 2014 Sep 17; 15:152.
[19]
Gopalakrishnan P, Ragland MM, Tak T. Gender differences in coronary artery disease: review of diagnostic challenges and current treatment. Postgrad Med. 2009 Mar; 121(2):60-8.
[20]
Akishita M. [Sex and gender differences in cardiovascular medicine]. Masui. 2009 Jan; 58(1):4-9.
[21]
Porębska M, Mazurek W. The influence of physical training on endothelial function in patients with stable coronary artery disease. Adv Clin Exp Med. 2014 Sep-Oct; 23(5):743-8.
[22]
Pack QR, Rodriguez-Escudero JP, Thomas RJ, Ades PA, West CP, Somers VK, Lopez-Jimenez F. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc. 2014 Oct; 89(10):1368-77.
[23]
Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V. Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med. 2007 Sep; 4(9):e270.
[24]
Zeller T, Müller C, Frank U, Bürgelin K, Schwarzwälder U, Horn B, Roskamm H, Neumann FJ. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003 Jun; 10(3):539-45.
[25]
Cianciaruso B, Ravani P, Barrett BJ, Levin A; ITA-EPO-7 investigators. Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease. J Nephrol. 2008 Nov-Dec; 21(6):861-70.
[26]
Ennezat PV, Maréchaux S, Pinçon C, Finzi J, Barrailler S, Bouabdallaoui N, Van Belle E, Montalescot G, Collet JP. Anaemia to predict outcome in patients with acute coronary syndromes. Arch Cardiovasc Dis. 2013 Jun-Jul; 106(6-7):357-65.
